Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2026-14 Crizotinib

Techniker Krankenkasse · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

November 30, 2028
Response Due
Active
Status

Opportunity Overview

Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130c Abs. 1 SGB V zu dem Wirkstoff Crizotinib im Rahmen eines Open-House-Verfahrens.

This Germany Health Services opportunity is one most of your competitors will never see.

How to bid: GlobalGov tracks this tender; it does not accept bids. Submit your response through the issuing agency’s official notice.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start a free GlobalGov account

Solicitation Details

Issuing agencyTechniker Krankenkasse
CountryGermany
CategoryHealth Services
CPV33600000
PublishedOctober 08, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNovember 30, 2028
StatusOpen — accepting responses
Original languageGerman — members read it in their own language
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Germany

Germany – Installation services (except software) – Netzwerk-Kommunikations-Infrastruktur
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-07
Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-14
Germany – Software package and information systems – Splunk Enterprise Security
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-27 - Ribociclib
Germany – Pharmaceutical products – Open-House-Originale-Rabattverträge 2025-09 - Cannabis
Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-13
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-15 - Tacrolimus (Retardtabletten)

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.